Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor or High Grade Glioma
and you are
between 2 and 21
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This pilot will study the feasibility and exploratory efficacy of using Cabozantinib for recurrent or refractory high grade glioma for which there are no curative options. Patients will also be followed for safety, time to progression, event free survival and overall survival

Provided treatments

  • Drug: Cabozantinib
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885324. The sponsor of the trial is Indiana University and it is looking for 10 volunteers for the current phase.
Official trial title:
Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children